tiprankstipranks
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
US Market

CASI Pharmaceuticals (CASI) Income Statement

Compare
447 Followers

CASI Pharmaceuticals Income Statement

Last quarter (Q3 2024), CASI Pharmaceuticals's total revenue was $7.79M, a decrease of -11.82% from the same quarter last year. In Q3, CASI Pharmaceuticals's net income was $-8.39M. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 33.88M$ 43.11M$ 30.17M$ 15.14M$ 4.13M
Gross Profit
$ 20.05M$ 27.28M$ 17.61M$ 5.63M$ 196.00K
Operating Expenses
$ 45.13M$ 53.77M$ 52.89M$ 38.95M$ 40.19M
Depreciation and Amortization
$ 3.74M$ 2.42M$ 3.10M$ 3.23M$ 2.15M
EBITDA
$ -21.54M$ -24.07M$ -32.75M$ -31.35M$ -37.43M
Operating Income
$ -25.08M$ -26.49M$ -35.28M$ -33.31M$ -39.99M
Other Income/Expenses
$ -1.21M$ -10.94M$ -560.00K$ -14.20M$ -5.37M
Pretax Income
$ -26.29M$ -37.43M$ -35.84M$ -47.51M$ -45.36M
Net Income
$ -26.94M$ -39.41M$ -37.77M$ -62.57M$ -51.41M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.02$ -2.89$ -2.78$ -5.66$ -5.36
Diluted EPS
$ -2.02$ -2.89$ -2.78$ -5.66$ -5.36
Weighted Average Shares Outstanding
13.36M 13.65M 13.61M 11.05M 9.59M
Weighted Average Shares Outstanding (Diluted)
13.36M 13.65M 13.61M 11.05M 9.59M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis